2012 Drugs that promote or inhibit coagulation

Thrombolytics: STREPTOKINASE, UROKINASE,
TISSUE PLASMINOGEN ACTIVATORS
(ALTEPLASE, RETEPLASE, TENECTEPLASE)

Common contraindications

Before administration of thrombolytic
After administration of thrombolytic
The fundamental problem with the action of thrombolytics is that they don't distinguish between "good" clots (such as the hemostatic plug shown here) and "bad" clots (thrombi). Thrombolytic drugs will degrade fibrin wherever it is found.
Email: Dr. Janet Fitzakerley | ©2012 University of Minnesota Medical School Duluth | Last modified: 31-may-12 7:46 PM